Sam Ravina
About Sam Ravina
Sam Ravina is an Equity Research Associate at Wedbush Securities in San Francisco, California, with a background in political science and finance. He has experience in investor relations and consulting, having previously worked at Sesen Bio and Blackstone.
Work at Wedbush Securities
Sam Ravina currently serves as an Equity Research Associate at Wedbush Securities, a position held since 2021. Based in San Francisco, California, he contributes to the firm's analysis and insights within the biotech sector. His role involves evaluating market trends, company performance, and financial data to provide informed recommendations to clients.
Previous Experience in Equity Research and Consulting
Prior to his current role, Sam Ravina gained valuable experience in the finance sector through various positions. He worked as a Consultant at Blackstone for four months in 2020 and 2021. Additionally, he served as an Investor Relations Analyst at Sesen Bio for four months in 2021 and as a Consultant there for nine months. His internships at Sesen Bio and DT Ward, PC further enhanced his understanding of the industry.
Education and Expertise
Sam Ravina holds a Bachelor of Arts in Political Science from Davidson College, where he studied from 2017 to 2021. He also completed a Business Valuation program at UCLA Extension in 2019. His academic background in political science, economics, and statistics supports his analytical skills in equity research, reflecting a diverse educational foundation.
Background in Sales and Internships
Before transitioning to finance, Sam Ravina worked as a Sales Associate at Aflac in 2018 for three months. He also completed internships at DT Ward, PC in 2019 and Sesen Bio in 2020. These experiences provided him with a broad perspective on business operations and client relations, contributing to his adaptability in various roles.
Interest in Business Strategy
Sam Ravina has a strong interest in business strategy, which is evident from his academic pursuits and current career in equity research. His combination of skills in political science and finance positions him well for analyzing market dynamics and developing strategic insights for clients in the biotech sector.